Search

everythinglearnresearchcommunity

for

Search:↓

Metformin combined with dyne-35 increases ovulation and pregnancy rates in PCOS patients.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Melatonin shortens the hair growth cycle by increasing PDGFA gene expression.

Vitamin D3 and parathyroid hormone-related peptide may have important uses in skin treatments.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

A man developed severe skin reactions after using a treatment for hair loss.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The PP2A-B55α protein is essential for brain and skin development in embryos.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

A single injection of PTH–CBD can increase bone density for up to a year.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

PRP injections are safe but don't significantly improve Peyronie's Disease.

A vitamin D receptor mutation causes rickets and affects immune responses.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

High doses of Tridax procumbens extract can be toxic, affecting liver and kidneys.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Biotin and acetazolamide improved hair and nail growth, mental function, and reduced headaches in a child with autism.